Results 1 to 10 of about 46,583 (263)

Spectrofluorimetric method for atenolol determination based on gold nanoparticles

Acta Pharmaceutica, 2018
A simple and sensitive spectrofluorimetric method for determination of atenolol (ATE) using gold nanoparticles (AuNPs) was developed. The method is based on the quenching effect of atenolol on photoluminescence of AuNPs at λem = 705 nm.
Bakir Esam, Gouda Mohamed, Alnajjar Ahmed, Boraie Waleed E.   +3 more
doaj   +1 more source

Post‐marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1128-1147, May 2026.
Abstract Objective Calcitonin gene‐related peptide (CGRP) inhibitors, including monoclonal antibodies (mAbs) and small‐molecule antagonists (gepants), have transformed migraine treatment. Although clinical trials established their efficacy and initial safety, post‐marketing surveillance is essential for understanding their real‐world safety profile in ...
Martina Giacon, Salvatore Terrazzino
wiley   +1 more source

Should socioeconomic factors be considered as traditional risk factors for cardiovascular disease, as confounders, or as risk modifiers? [PDF]

, 2008
A large number of studies show that cardiovascular disease and its traditional risk factors are associated with socioeconomic conditions. However, their etiological role in the development of cardiovascular outcomes is not always well understood ...
De Vogli, R., Marmot, M.
core  

THE EFFECT OF COPROCESSED SUPERDISINTEGRANTS RATIO (CROSPOVIDONE-SODIUM STARCH GLYCOLATE) TO THE PHYSICOCHEMICAL CHARACTERISTICS OF ATENOLOL ORALLY DISINTEGRATING TABLETS [PDF]

, 2018
Objective: The objective of this study was to evaluate the effect of coprocessed superdisintegrants (crospovidone-sodium starch glycolate) ratio 1:1; 1:2; and 1:3 to the physicochemical characteristics of atenolol orally disintegrating tablets. Methods:
., Meilany, Parfati, Nani, Rani, Karina Citra   +2 more
core   +1 more source

Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension

Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 3, Page 267-273, May 2026.
ABSTRACT The pharmacokinetics of sildenafil are ill‐defined in dogs with naturally occurring pulmonary hypertension (PH). Because the plasma concentrations of sildenafil have not been reported for dogs with this disease, this study aimed to describe the population pharmacokinetics of sildenafil in a sample of dogs with PH. Twenty client‐owned dogs with
Mariko Yata, Teresa C. DeFrancesco, John D. Bonagura, Mark G. Papich   +3 more
wiley   +1 more source

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL

Рациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid and glucose metabolism and cardiovascular remodeling in hypertension. Material and methods.
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto   +7 more
doaj   +1 more source

Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need [PDF]

, 2005
Background There is a small, but growing body of literature highlighting inequities in GP practice prescribing rates for many drug therapies. The aim of this paper is to further explore the equity of prescribing for five major CHD drug groups and to ...
A Gibson, A Majeed, A Majeed, A Majeed, A Williams, AM Tod, Antony S St Leger, B Hope, BH Foundation, C Baxter, C Packham, C Packham, D Health, D Health, D Health, D Health, DC Lloyd, DC Lloyd, EUROASPIREII Group., FA Majeed, FA Majeed, FDA Reid, G Davey-Smith, G Davey-Smith, GC Fonarow, H Cooper, H Tunstall-Pedoe, J Bedson, J Hippisley-Cox, J Tudor Hart, JHS Unit, JI Mann, JY Nazroo, K Gardner, M Frischer, M Goddard, M Pringle, M Whitehead, M Whitehead, MC MacLeod, MG Hunink, MG Patel, N Bradshaw, N Chaturvedi, N Danchin, N Rice, NC Campbell, NHS Centre for Reviews and Dissemination, ON Statistics, P Jousilahti, P Primatesta, P Suadicani, P Townsend, Paul R Ward, Peter R Noyce, PG Steg, PH Whincup, PR Ward, PR Ward, PR Ward, PS Unit, PS Unit, R Bhopal, R Bhopal, RM Haynes, S Hopper, S Kerrison, S Langham, S Peckham, SM Bogle, SR Chapman, SS Gottlieb, T Crayford, T Morton-Jones, T Walley, TJ Wang, V Salomaa, WH Organisation.   +77 more
core   +4 more sources

Hypertension [PDF]

, 2004
Hypertension is a rapidly moving clinical field with frequent developments in new pharmacologic agents and management strategies. Perhaps more importantly, there have been substantial improvements in our understanding of how best to use the drugs ...
Farrugia, Emanuel
core  

A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris

Терапевтический архив, 2013
AIM: To evaluate the efficiency and safety of an interchange of atenolol and ivabradine in patients who had stable angina pectoris without myocardial infarction in the history and left ventricular (LV) systolic dysfunction/MATERIAL AND METHODS: The trial
A A Shavarov, G K Kiiakbaev, Zh D Kobalava   +2 more
doaj  

An investigation of the impact of atenolol on the risk of all-cause mortality in Asian individuals with hypertension and cardiovascular conditions

Bulletin of the National Research Centre
Background Despite several justifications for utilizing beta-blockers, such as atenolol, as the initial treatment for hypertension in the presence of cardiovascular disease, some studies have demonstrated that calcium channel blockers were more effective
Abdullah Alkattan, Eman Alsalameen, Alaa Harmoush, Mhd Nour Farawati, Hind Alsharif, Nagla Mahmoud, Mhd Ali Farawati, Amjad Alfaleh, Mahmoud Kandeel, Nashwa Radwan   +9 more
doaj   +1 more source